APPLIED PRECLINICAL SCIENCE

EG-LAS Research & Development

The R&D division drives EG-LAS’s applied preclinical research agenda — designing and executing animal models, wound-healing and surgical studies, and pharmacological trials that generate scientifically sound, ethically governed data for the research community.

Driving Preclinical Innovation

Our **Research & Development** division bridges the critical gap between early-stage laboratory chemical discovery and clinical-phase pharmaceutical trials. We collaborate closely with Cairo University and leading national institutions.

Focus Areas

Study design, IACUC-compliant protocol development, surgical and pharmacological animal models, and cross-institutional research collaboration in laboratory animal science.

Preclinical Capabilities

Detailed list of specialized preclinical methodologies governed by our research experts.

1. Study Design & Ethical Review

Structuring preclinical studies from hypothesis to protocol, with ethical review built in from the start.

2. Surgical & Wound-Healing

Designing and executing surgical animal models, including wound-healing and tissue-repair studies.

3. Pharmacological Studies

Extract-based and pharmacological intervention studies evaluating therapeutic candidates in animal models.

4. Data Analysis & Reporting

Rigorous statistical analysis and scientific reporting that stands up to peer review.

5. IACUC Documentation

Full ethical approval documentation prepared for Cairo University’s IACUC and equivalent bodies.

6. Cross-Division Collaboration

Working alongside URAF and CTC-LAS to move research from design through facility execution.

Representative Research Areas

Standard disease and physiological pathways supported inside our labs.

A. Wound Healing Models

Tissue-defect and repair studies evaluating healing dynamics under controlled surgical conditions.

B. Endocrine & Hormonal

Induced-model studies examining hormonal conditions and candidate therapeutic responses.

C. Plant-Extract Interventions

Evaluating natural and plant-derived compounds as therapeutic interventions in animal models.

D. Pathology Models

Species-appropriate models investigating organ-specific conditions and treatment response.

Ethical Governance & RFQ Submission

Every R&D study is designed and reviewed under **Cairo University’s Institutional Animal Care and Use Committee (IACUC)** framework — ensuring welfare, scientific validity, and regulatory compliance are considered together from the earliest planning stage.

Preclinical Study Design Consultation

Structuring preclinical studies from hypothesis to protocol, with ethical review built in from the start.

Surgical & Wound-Healing Models

Designing and executing surgical animal models, including wound-healing and tissue-repair studies.

Pharmacological & Extract-Based Studies

Extract-based and pharmacological intervention studies evaluating therapeutic candidates in animal models.

Preclinical Data Analysis & Reporting

Rigorous statistical analysis and scientific reporting that stands up to peer review.

EG-LAS Research & Development

**Affiliation:** Cairo University · Giza, Egypt
**Email:** rd@eglas.org.eg

Ethical Governance

• CAIRO UNIVERSITY IACUC GOVERNED
PRECLINICAL R&D REVIEWS

What Lead Investigators Say

★★★★★
Preclinical R&D Research

“The preclinical pharmacokinetic and wound healing models executed by the EG-LAS R&D division yielded rigorous, publication-ready data accepted by top-tier Q1 journals without revisions.”

Prof. Dr. Ahmed Al-Ghamdi

Prof. Dr. Ahmed Al-Ghamdi

Chair of Drug Discovery & Biotechnology
★★★★★
Preclinical R&D Research

“Outstanding precision in protocol design, statistical reporting, and ethical IACUC compliance. EG-LAS is our trusted scientific partner for all our in-vivo validation and therapeutic studies.”

Dr. Yasmin Samir

Dr. Yasmin Samir

Lead Investigator, Regenerative Medicine Group